SOX11 and lymphoma: MCL tumor cells showed increased expression of SOX11 compared to both other lymphomas (FLCD3-) and non-malignant infiltrating cells (MCLCD3+). This was manifested either as increased ΔMFI (Figure6b) or fraction of SOX11 positive cells (Figure6c).